ArTS Archivio della ricerca di Trieste

ROVIELLO, GIANDOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.322
EU - Europa 2.883
AS - Asia 1.144
SA - Sud America 13
AF - Africa 10
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.383
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.301
PL - Polonia 1.629
IT - Italia 364
CN - Cina 357
SG - Singapore 343
SE - Svezia 337
HK - Hong Kong 210
UA - Ucraina 124
TR - Turchia 100
DE - Germania 81
IE - Irlanda 73
FI - Finlandia 70
BG - Bulgaria 69
GB - Regno Unito 45
VN - Vietnam 39
IN - India 24
MY - Malesia 19
BE - Belgio 17
CA - Canada 17
NL - Olanda 14
JP - Giappone 13
RU - Federazione Russa 12
KR - Corea 11
IL - Israele 10
BR - Brasile 9
FR - Francia 9
CH - Svizzera 7
AU - Australia 5
GR - Grecia 5
DZ - Algeria 4
ES - Italia 4
IR - Iran 4
MD - Moldavia 4
MX - Messico 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AT - Austria 3
EG - Egitto 3
NZ - Nuova Zelanda 3
RO - Romania 3
SI - Slovenia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ID - Indonesia 2
LT - Lituania 2
SA - Arabia Saudita 2
TN - Tunisia 2
AZ - Azerbaigian 1
BO - Bolivia 1
CL - Cile 1
EE - Estonia 1
HU - Ungheria 1
IQ - Iraq 1
MA - Marocco 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
TH - Thailandia 1
Totale 10.383
Salva come PNG Salva come JPEG
Città #
Warsaw 1.623
Fairfield 1.006
Woodbridge 605
Ashburn 522
Houston 515
Wilmington 445
Chandler 424
Seattle 424
Ann Arbor 401
Cambridge 385
Singapore 303
Hong Kong 201
Jacksonville 183
Trieste 152
Princeton 143
Boardman 119
Beijing 96
Izmir 94
Columbus 93
Dublin 73
Santa Clara 73
Sofia 69
San Diego 56
Dearborn 37
Dong Ket 34
Bremen 32
Helsinki 30
Redwood City 25
Dongguan 16
Hefei 16
Brussels 15
Chicago 14
Duino-Aurisina 13
Falls Church 13
Nanjing 13
Phoenix 13
Munich 12
Kunming 11
Montegaldella 11
Jinan 10
Norwalk 10
Fremont 9
Shanghai 9
Udine 9
London 8
Tel Aviv 8
Tianjin 8
Toronto 8
Des Moines 7
Eagan 7
Florence 7
Guangzhou 7
Milan 7
Mumbai 7
New York 7
Pignone 7
Redmond 7
San Francisco 7
Shenyang 7
Changsha 6
Hangzhou 6
Lappeenranta 6
Los Angeles 6
Nanchang 6
Padova 6
Rho 6
Baltimore 5
Bloomsbury 5
Buffalo 5
Richardson 5
Tappahannock 5
Venezia 5
Amsterdam 4
Bergamo 4
Cagliari 4
Chisinau 4
Delhi 4
Erlangen 4
New Delhi 4
Rome 4
Tokyo 4
Athens 3
Cairo 3
Chengdu 3
Crema 3
Deiva Marina 3
Durham 3
Edinburgh 3
Flemington 3
Fuzhou 3
Ho Chi Minh City 3
Kocaeli 3
Ningbo 3
Taiyuan 3
Taizhou 3
Venice 3
Zhengzhou 3
Auckland 2
Barnsley 2
Barrhaven 2
Totale 8.628
Salva come PNG Salva come JPEG
Nome #
Advances in systemic therapy for metastatic breast cancer: future perspectives 322
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene 316
Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma 313
Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer 293
Isolated testicular metastasis from prostate cancer 292
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility 283
Bevacizumab in small cell lung cancer 282
Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer 273
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma 260
Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer 259
Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials 242
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma 242
PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy 237
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 205
Advances in systemic therapy for malignant mesothelioma: Future perspectives 175
Immune checkpoint inhibitors in pre-treated gastric cancer patients: Results from a literature-based meta-analysis 174
Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer 169
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis 168
Results from a meta-analysis of immune checkpoint inhibitors in first-line renal cancer patients: does PD-L1 matter? 168
Corticosteroid switch after progression on abiraterone acetate plus prednisone 159
Apatinib for the treatment of gastric cancer 156
Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis 155
Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer? 146
Different efficacy of ramucirumab in patients with metastatic gastric and gastroesophageal junction cancer according to ECOG performance status 145
Is there still a place for vinorelbine in advanced metastatic castration resistant prostate cancer? 144
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 139
Pertuzumab therapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer 138
Lenvatinib for the treatment of renal cell carcinoma 136
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer 135
The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials 134
Tumour Infiltrating Lymphocytes and Immune-Related Genes as Predictors of Outcome in Pancreatic Adenocarcinoma 132
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 131
Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer? 129
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer 128
Risk of hypertension with ramucirumab-based therapy in solid tumors: data from a literature based meta-analysis 128
Is the fatigue an adverse event of the second generation of hormonal therapy? Data from a literature-based meta-analysis 127
Influence of Age and the Gleason Score in the Choice of Novel Hormonal Therapies before and after Chemotherapy 123
Lower urinary tract infections from external beam radiation therapy in prostate cancer: A single institution experience 123
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 122
Familial aggregation of gastric cancer with microsatellite instability** 121
Single Center Experience on Anatomy-and Histopathology-Based Gastric Cancer Molecular Classification 115
Is still there a place for orteronel in management of prostate cancer? Data from a literature based meta-analysis of randomized trials 114
Is there a place for bevacizumab in patients with extensive-stage small cell lung cancer? 114
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer 113
Is still there a role for IL-2 for solid tumors other than melanoma or renal cancer? 112
New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials 110
Efficacy of extended aromatase inhibitors for hormone-receptor–positive breast cancer: A literature-based meta-analysis of randomized trials 109
No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials 108
Is it time for everolimus-based combination in castration-resistant prostate cancer? 108
A Phase II study of olaparib in breast cancer patients: Biological evaluation from a 'window of opportunity' trial 107
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 104
Neoadjuvant chemotherapy and radical radiotherapy associated with cetuximab for laryngeal cancer in a pancreas and renal recipient 103
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis 101
Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033 99
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 99
Expanding treatment options for metastatic gastric cancer 98
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis 98
Role of targeted agents in neuroendocrine tumors: Results from a meta-analysis 97
Surgical management of advanced gastric cancer: An evolving issue 97
Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxel 95
Is the Gleason score the driver for the treatment decision-making of patients with castration-resistant prostate cancer in the new era of the anti-androgenic therapies? 92
EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience 92
Re: Karim Fizazi, Kim N. Chi, Johann S. de Bono, et al. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.035: Corticosteroid-associated Adverse Events in Elderly Patients 87
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 86
Apatinib in metastatic gastric cancer: Can paclitaxel make the difference? 81
Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies 81
Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis 78
Avelumab in gastric cancer 76
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer 63
Cancer management during the COVID-19 world pandemic 45
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 41
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature 39
P53 antibodies as a diagnostic marker for cancer: A meta-analysis 39
Effects of Whole Pelvic Radiotherapy on the Distribution of Lymphocyte Subpopulations in Prostate Cancer Patients 34
Combining inhibition of immune checkpoints and PARP: rationale and perspectives in cancer treatment 23
Optimal primary end point in Phase II trials of immune checkpoint inhibitors for advanced solid cancers: An evolving issue 22
Updates on the CDK4/6 inhibitory strategy and combinations in breast cancer 21
Immune-gene signature: A new tool for patient selection for checkpoint inhibitors? 21
New-Generation Hormone Therapies in Nonmetastatic Castration-Resistant Prostate Cancer: Why, Who, When 15
The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study 13
Totale 10.674
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.475
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.762 0 0 0 0 181 286 267 181 250 283 185 129
2020/20212.199 211 236 222 171 254 218 202 170 111 191 71 142
2021/2022858 78 76 58 40 8 70 53 33 130 118 61 133
2022/20231.251 109 145 127 185 113 211 13 104 158 14 46 26
2023/2024751 36 80 44 56 34 73 140 144 2 38 48 56
2024/2025845 24 190 366 132 133 0 0 0 0 0 0 0
Totale 10.674